The Assura Group is a healthcare technology company that focuses on developing new medical devices and software. The company went public in 2014 and its share price has been steadily rising since then. In the past year, the stock has gained nearly 50%.
Analysts believe that the company’s strong fundamentals and innovative products will continue to drive growth in the future.
The Assura Group is a leading provider of healthcare products and services in the United Kingdom. The company offers a wide range of products and services to meet the needs of patients, families, and healthcare professionals. The Assura Group is committed to providing quality products and services that improve the lives of patients and their families.
Ziyarat Ashura
Assura Reit
Assura Reit is a publicly traded real estate investment trust focused on owning and operating primary care medical office buildings across the United States. Assura’s portfolio consists of approximately 475 properties, leased to more than 250 customers, located in 37 states.
Credit: www.mddionline.com
What is the Assura Share Price
The Assura share price is currently trading at around £1.50 per share. The company is a UK-based healthcare property group that owns and manages around 800 healthcare properties across the country. The company has a market capitalisation of just over £600 million and is listed on the London Stock Exchange.
How Has the Assura Share Price Performed Over Time
In 2008, the Assura share price was $2.85. In 2018, the Assura share price was $5.40. This represents a compound annual growth rate of 7.3%.
Why Might the Assura Share Price Move in a Certain Direction
When it comes to assessing share prices, there are a number of key drivers that can impact the direction in which a company’s share price may move. In the case of Assura, some of the key drivers that could impact its share price include earnings releases, dividends announcements, analyst ratings and price target changes, as well as general newsflow surrounding the healthcare sector. Let’s take a closer look at each of these drivers in turn.
Earnings releases: One key driver of share price movement is earnings releases. If a company posts strong quarterly results that exceed analyst expectations, this is often seen as a positive catalyst for the stock, which could lead to an uptick in the share price. On the other hand, if a company misses on earnings or provides weak guidance for the future, this could weigh on the stock and lead to a sell-off.
Dividends announcements: Another key driver for share prices is dividend announcements. Companies that regularly pay out dividends tend to be more shareholder-friendly and this is often reflected in their stock price performance. Therefore, when Assura announces its next dividend payment, this could provide some support for the stock and lead to a slight uptick in the share price.
Analyst ratings and price target changes: Analyst ratings and price target changes can also have an impact onshare prices. If analysts upgrade their rating on a stock or raise theirprice target (the level at which they believe the stock will reach),this is generally seen as positive news flow for the company concernedand can lead to an increase in its share price.
What Do Analysts Think About the Assura Share Price
The Assura share price has been on a roller coaster ride over the past year. After reaching an all-time high in December 2017, the share price fell sharply in early 2018 before bouncing back and then falling again. At the time of writing, the share price is around $1.60, which is well below the all-time high but still above the lows seen earlier this year.
So what do analysts think about Assura’s current share price? Overall, the analyst consensus is that Assura is a hold. This means that analysts believe that investors who already own Assura shares should hold onto them, but those who don’t own shares shouldn’t buy them at current levels.
There are a few reasons for this cautious stance on Assura. Firstly, there are concerns about government reimbursement rates for healthcare services in the UK, which could impact Assura’s business going forward. Secondly, competition in the healthcare real estate sector is increasing, which could put pressure on rental rates and occupancy levels at Assura’s properties.
That said, there are also some positive factors to consider. Analysts believe that Assura’s management team is strong and experienced, and they are confident in their ability to navigate these challenges successfully. In addition, many of Assura’s properties are located in areas with significant population growth potential, which could provide tailwinds for future growth.
Conclusion
The Assura share price has been on a rollercoaster ride in recent years. After hitting an all-time high in 2015, the shares fell sharply in value following the Brexit vote and the company’s decision to delist from the London Stock Exchange. However, they have since recovered some of their lost ground and are currently trading at around £1.20.
Despite this volatility, Assura remains a popular investment option for income seekers as it offers a dividend yield of 7%.
